Targeting mitochondria for cancer treatment - two types of mitochondrial dysfunction

Jiří Pokorný1, Jan Pokorný2, Jitka Kobilková3

  • 1Institute of Photonics and Electronics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.

Prague Medical Report
|January 29, 2015
PubMed

Insights

Mitochondrial dysfunction characterizes cancer cells (Warburg effect) or their supporting fibroblasts (reverse Warburg effect). This dysfunction impacts cell metabolism, membrane potential, and electromagnetic activity, offering potential therapeutic targets.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Cancer exhibits two metabolic phenotypes: the Warburg effect (mitochondrial dysfunction in cancer cells) and the reverse Warburg effect (functional mitochondria in cancer-associated fibroblasts).
  • Mitochondrial membrane potential and oxidative metabolism are key indicators differentiating these cancer types.

Purpose of the Study:

  • To investigate the relationship between mitochondrial function, cellular metabolism, and electromagnetic properties in different cancer types.
  • To explore the role of ordered water layers (exclusion zones) in mitochondrial function and cancer progression.

Main Methods:

  • Measurement of inner mitochondrial membrane potential using fluorescent dyes like Rhodamine 123.
  • Analysis of oxidative metabolism, proton layers, and microtubule electric polar vibrations.
  • Characterization of electromagnetic frequency spectra in cancer cells and fibroblasts.

Main Results:

  • Mitochondrial dysfunction correlates with reduced oxidative metabolism and altered membrane potential.
  • Ordered water layers influence proton distribution and damping of electric polar vibrations.
  • Distinct electromagnetic frequency shifts observed in Warburg and reverse Warburg effect cells, linked to aggressiveness and generalization.

Conclusions:

  • Mitochondrial dysfunction is a critical factor in cancer development and aggressiveness.
  • Metabolic and electromagnetic alterations in cancer cells, influenced by mitochondrial status, disrupt tissue control.
  • Targeting mitochondrial dysfunction presents a promising therapeutic strategy for cancer treatment.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K